Back to Search Start Over

Patent Issued for Compositions and methods for treating Helicobacter pylori infection (USPTO 12070456).

Source :
Cancer Vaccine Week; 9/19/2024, p74-74, 1p
Publication Year :
2024

Abstract

The article reports that the Hospital for Sick Children in Toronto, Ontario has been granted U.S. Patent No. 12070456 for methods and compositions aimed at treating Helicobacter pylori infections. Topics discussed include the use of transient receptor potential mucolipin 1 (TRPML1) modulators in cancer treatment, alternative therapies for respiratory infections, and agents that promote autophagosome maturation for various disorders.

Details

Language :
English
ISSN :
15436810
Database :
Complementary Index
Journal :
Cancer Vaccine Week
Publication Type :
Periodical
Accession number :
179616057